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Tobacco smoking is a major source of preventable 
morbidity and mortality worldwide particularly due 
to lung tumours and/or cardiovascular pathologies. 
Continued tobacco smoking is primarily driven by 
dependence on nicotine, one of the main psychoactive 
ingredients of tobacco smoke, which initiates a series of 
adaptive changes in brain neurons and circuits by binding 
with high affinity to neuronal nicotinic acetylcholine 
receptors (nAChRs) [1].
Nicotine is a highly lipophilic compound and, once 
in the blood stream, rapidly crosses the blood brain barrier 
and accumulates in the brain. nAChRs are a family of 
pentameric ion channels, whose variety is mainly due to 
the diversity of the possible homomeric or heteromeric 
combinations of nine α (α2−α10) and three β (β2−β4) 
subunits, which respond to endogenous neurotransmitter 
acetylcholine (ACh) and exogenous nicotine. Interestingly, 
the half-life of nicotine in brain tissue, is much longer 
than that of ACh because acetylcholinesterase does not 
hydrolyse nicotine, which is only metabolised by liver 
enzyme [2]. nAChRs are widely and unevenly distributed 
in the central nervous system (CNS). The majority of them 
have a presynaptic and/or preterminal localisation, where 
they modulate the release of many neurotransmitters, 
whereas those in the peripheral nervous system have 
a postsynaptic localisation and mediate fast synaptic 
transmission. 
Chronic exposure to cigarette smoke or nicotine 
gives rise to neural adaptations. One prominent 
neuroadaptation in the brain of humans and animals 
chronically exposed to nicotine [3] is the cell and region-
specific up-regulation of nAChRs [4] that leads to change 
in downstream plasticity at molecular, cellular and circuit 
levels [1]. 
The α4β2 nAChR subtype is the most highly 
expressed subtype in the CNS and when is expressed in 
heterologous systems can exist in alternate (α4β2)
2
α4 
and (α4β2)
2
β2 stoichiometries that have different calcium 
permeability and agonist or antagonist sensitivity [5]. In 
both stoichiometries two ACh binding site located at α4/
β2 subunit interfaces are present, but in the (α4β2)
2
α4 
stoichiometry an additional ACh binding site, with low 
affinity for ACh, is also present at the α4/α4 interface [5].
Prolonged exposure to nicotine in vivo, increases 
the number of α4β2 nAChR binding sites as a result of 
an increase in α4 and β2 subunit protein levels without 
any change in mRNA levels (reviewed in [6]). This up-
regulation in the brain is not uniform and so we analyzed 
the effect of chronic (14 days) nicotine on the expression 
of α4β2 nAChRs in the cortex and thalamus, two brain 
regions of C57Bl/6 mice that respond differently to 
nicotine [7]. We found that the α4 and β2 subunits under 
control conditions, are only present in assembled α4β2 
receptors in the cortex and thalamus and in this latter 
region a significantly higher proportion of receptors have 
the (α4β2)
2
β2 stoichiometry. 
The chronic in vivo administration of nicotine at 
a concentration that is in the range of that found in the 
blood of heavy smokers, more markedly up-regulated 
α4β2 nAChRs in the cortex than those in the thalamus. 
This up-regulation was paralleled by an increased 
proportion of receptors with (α4β2)
2
β2 stoichiometry in 
the cortex but not in the thalamus. The up-regulation and 
altered stoichiometry are transient because they returned 
to control levels with an average half-time of 2.7 days 
after nicotine withdrawal. This change in stoichiometry 
is very important because it can greatly influence the 
physiological response of neurons to nicotine and ACh. 
What may be the mechanism(s) by which nicotine 
interferes with nAChR expression?
The assembly of nAChRs is a slow and inefficient 
process. nAChR subunits cannot leave the endoplasmic 
reticulum (ER) until they have reached their correctly 
folded conformation, and any misfolded or unassembled 
proteins are retro-translocated from the ER to the 
cytoplasm for proteasomal degradation. After subunit 
assembly into pentamers in the ER, transport-competent 
nAChRs are recruited at ER exit sites and pass through 
COPII vesicles to the Golgi apparatus and then to the 
plasma membrane [2, 6]. This tight quality control 
guarantees that only corrected fully assembled receptors 
reach the cell surface. The assembly of nAChRs in the 
ER and their transport to the cell surface is therefore 
crucially important for regulating the efficacy of synaptic 
transmission.
Although our study does not indicate the pathways 
by means of which nicotine favors the increase in cortical 
(α4β2)
2
β2 receptors, previous studies of heterologous 
systems have shown that its up-regulatory effect is due to 
its interactions with intracellular and not surface exposed 
receptors [1, 2, 6]. The suggested mechanisms include: 
nicotine ability to assist the assembly and stabilization of 
pentamers (those with the (α4β2)
2
β2 stoichiometry), and 
to increase receptor export from the ER. 
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Another possible mechanism by means of which 
nicotine can increase the expression of nAChRs with a 
(α4β2)
2
β2 stoichiometry is by regulating the interaction 
between nAChR subunits and modulating proteins. 
Nichols et al., 2014, [8] have recently shown that Lynx1, 
a glycosylphosphatidylinositol-anchored neurotoxin-like 
receptor binding protein, by binding the α4 subunit in the 
ER favors the formation of the α4/α4 dimer and biases 
the formation of nAChR with the (α4β2)
2
α4 stoichiometry. 
It is thus possible that the brain region-specific 
up-regulation of nAChRs caused by chronic nicotine 
exposure may at least partially be due to the differential 
expression of modulating proteins, such as Lynx1, in 
different neuronal cell types. In regions such as the cortex, 
where receptors with the (α4β2)
2
α4 stoichiometry prevail 
under control conditions, the presence of nicotine (which 
is known to bind to the α4/β2 interface), may hamper the 
physiological formation of the α4α4dimer, thus leading 
to the higher expression of nAChRs with the (α4β2)
2
β2 
stoichiometry, and altering the intracellular receptor 
population that reaches the plasma membrane. 
In conclusion, the crucial effects of chronic nicotine 
exposure are intracellular and include a cell-specific 
influence on the assembly and stoichiometry of the 
nAChRs exported to the plasma membrane, that affects the 
function of surface nAChRs and cholinergic transmission. 
We believe that the mechanism of nicotine action 
on α4β2 receptors reported here may be also relevant 
for other nAChR subtypes. It is, indeed, worthwhile to 
consider extraneuronal tissues, especially where nicotine 
may reach much higher concentrations such as the lung 
epithelia. Many peripheral cell types and tissues express 
nAChR subunit transcripts, that may play crucial roles in 
signal transduction underlying tumor initiation or growth 
[9].
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